Alnylam

Events & Presentations

Alnylam Pharmaceuticals Conference Call to Discuss Givosiran Phase 1 Clinical Results
06.26.2017
8:00 AM ET
PDF View Presentation  723.2 KB   Add to Briefcase

Back to previous page